Furthermore, the NPC samples were examined for distinct E–M differentiation states by immunofluorescence analysis and results showed that the E (CD104+CD44low), E/M (CD104-CD44high) and xM (CD104+CD44high) prototypes existed in these NPC tumors (Fig 5J). The gene discussed is ITGB4; the disease is nasopharyngeal carcinoma.